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In November 1994 methyl parathion (MP)
was found to have been illegally sprayed by an
unlicensed pesticide applicator in more than
400 residential properties of Lorain and
Elyria, Ohio (1). By May 1997 MP was
believed to have been applied in 4,500 proper-
ties in Mississippi and Louisiana. Hundreds of
properties in Illinois and Tennessee were also
contaminated with MP (2). Spraying was gen-
erally conducted in poor, urban communities
primarily to control cockroaches (1,2). MP is
a restricted organophosphate (OP) pesticide
for use only on agricultural crops by certiﬁed
applicators (3). Outdoors, MP breaks down
within a few days because of biodegradation
and contact with water (4). As found in Ohio
and other locations, inside homes, MP can
remain for years. MP is highly toxic, with a
lethal dose in 50% of rats tested (LD50) of
12–24 mg/kg (4,5). Deaths have occurred
from oral ingestion of MP and from a combi-
nation of dermal and inhalation exposure (6).
Two children, 4 and 11 years of age, died
when a 4% MP spray was illegally applied to
the interior of a Mississippi home (7).
The pesticide applicator in Ohio had
treated properties with MP solutions averag-
ing 6.5% as determined by analyses of MP
solutions left with residents in juice jars and
cleaning bottles. Spraying occurred in
kitchens, including inside cabinets, bath-
rooms, living rooms, and bedrooms. Sofas
and chairs were sometimes sprayed. MP col-
lected from floor baseboards and splash-
boards of kitchen countertops in 28
properties averaged 100 µg MP/100 cm2 (8).
Surface levels of up to 890 µg MP/100 cm2
were found on kitchen counter splashboards.
A child’s food dish was found to have 6,000
µg MP. Personal clothing and home furnish-
ings (e.g., furniture, drapes, and carpeting)
were found to have detectable levels of MP.
Air levels averaged 7.5 µg/m3, with a maxi-
mum value of 30 µg/m3. The U.S. Centers
for Disease Control and Prevention (CDC)
detected p-nitrophenol (PNP), an MP meta-
bolic byproduct, in the urine of residents
whose properties had been sprayed with MP.
Urine PNP levels as high as 4,800 µg/L
(11,000 µg/L, creatinine adjusted) were
found in a 4-year-old child (9). These values
are in the range of those found in children
who became ill or died of MP exposure in
Mississippi (7).
Based on the high acute toxicity of MP,
environmental levels within residences, and
known exposures, in November 1994 an
interagency group was formed by the U.S.
Environmental Protection Agency (U.S.
EPA), CDC, Agency for Toxic Substances
and Disease Registry (ATSDR), National
Institute for Occupational Safety and Health
(NIOSH), Ohio Department of Health and
Department of Agriculture, Lorain County
and Lorain City health departments, Elyria
Health Department, U.S. Coast Guard
National Strike Force, Lorain County
Human Services, Salvation Army, and
American Red Cross (1,4,5). This group was
charged with developing health criteria to
determine which residents should be
temporarily relocated, how to handle
relocations, which properties should be
decontaminated, and what were the most
effective decontamination methods. The cri-
teria developed were initially based on con-
ventional risk assessment techniques that
required many assumptions. As more infor-
mation was obtained on the relationships
between environmental levels and exposure in
Ohio and then in other states, the decision-
making criteria were reﬁned. This process of
data collection, health risk evaluation, and
decision making is described in this article.
Methods
Sampling. An environmental protocol was
developed for the purpose of gathering each
sprayed residence in MP data to a) assess
potential exposures and health risks, b) pro-
vide a basis for enforcement actions, and c)
determine properties and areas within proper-
ties in need of decontamination. In each
sprayed residence in Lorain, a total of six
100-cm2 surface wipe samples were taken,
one from each of the following areas: the
kitchen baseboard immediately adjacent to
the refrigerator, kitchen counter splashboard
in a food preparation area, under the kitchen
sink adjacent to the drain pipe, living room
under a heat register, bathroom baseboard
under the lavatory, and bedroom baseboard
(based on descending priority of children < 5
years of age, pregnant women, and adults).
Samples for MP and other OPs (e.g.,
chloropyrifos) were collected by wiping the
area inside a 10 × 10 cm template with gauze
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pads charged with isopropyl alcohol, which
were then placed in glass vials. Field blanks
were also collected. A single 4-hr air sample
was collected from the top of the kitchen
refrigerator using sampling pumps (Mine
Safety Appliance, Pittsburgh, PA, USA) pre-
calibrated at 1 L/hr, fitted with an SKC
XAD-2 sampler tube (SKC, Inc., Eighty
Four, PA, USA). Environmental PNP wipe
samples were collected from a very small sub-
set of properties by swabbing a 10 × 10 cm
area, first with a gauze pad charged with
isopropyl alcohol and then with a second
gauze pad charged with distilled water.
Both gauze wipe samples and XAD air
absorbent material were extracted for 1 hr in
acetone, and the residue was dissolved with
10% acetone in hexane. Analysis was per-
formed with a Hewlett Packard 5890 Series II
gas chromatograph (Hewlett Packard, Palo
Alto, CA, USA) with a DB-1, DB-5 (J&W
Scientific, Folsom, CA, USA), or HP-1
(Hewlett Packard) capillary column and a
flame photometric (detector D) or a mass-
selective detector (Hewlett Packard). Quality
control steps included ensuring that replicate
standards were within ±15%, running blanks
every 10 samples, and confirming the OP
with a second detector.
PNP samples were extracted with ethyl
acetate acidified with sulfuric acid, and the
residues were washed with methylene chlo-
ride followed by hexane. The final residue
was diluted with acetonitrile and analyzed by
high-performance liquid chromatography
(Waters 600-MS) coupled to a photo diode
array detector, ﬁtted with a Nova-Pak C18 60
A4 µm column (Waters Corp., Milford, MA,
USA). Quality control steps required that
replicate standards be within ±15%, and
blanks were run every 10 samples.
Toxicology and risk evaluation. A review
of MP toxicology was necessary to assess acute
and chronic hazards and to develop a risk-
based approach to establish criteria for multi-
ple routes of exposure. The evaluation below
is not intended to be an exhaustive literature
review but to reflect the actual evaluation
process used to address MP contamination in
residences. Extensive literature reviews are
available elsewhere (6).
Short-term acute exposures to children
from ingestion or dermal exposure to MP
liquids in Ohio were of particular concern.
Direct ingestion of 1.8–3.6 mL of 6.5% MP
by a 10-kg, 1-year-old child would yield oral
doses in the range of LD50 levels reported in
animal studies. LD50 studies for dermal expo-
sure to MP range from 67 to 120 mg/kg in
rats (4,5). Extrapolating, dermal contact with
10–35 mL of a 6.5% MP solution, as found
in Ohio residences, would be potentially lethal
to a 10-kg child. As a result of these ﬁndings,
hazardous materials teams conducted searches
of Ohio properties where MP had been
sprayed, removing a total of 15 unmarked
containers left by the applicator after treating
the properties. Another 20 containers were
later removed by decontamination teams.
Because there was a potential for acute
poisoning, questionnaires and interviews
were developed and conducted by health
agencies to assess adverse health effects and
the need for medical follow-up. Although
not used for a primary relocation criterion,
an OP symptom list was developed. Medical
follow-up was recommended when two or
more symptoms (e.g., severe headache, inco-
ordination, muscle twitching/tremors,
difficulty breathing, vomiting, diarrhea,
involuntary urination) were self-reported.
Voluntary, low-dose oral studies from the
1960s provided effects information on MP
(8,9). At oral dosages of 6.5–7.0 mg/day, or
approximately 0.1 mg MP/kg/day, plasma
cholinesterase (ChE) was found to be
depressed by 10% relative to controls in a 
59-day study (10). At dosages averaging
7.0–9.0 mg/day (0.1 mg MP/kg/day) for 30
days, red blood cell (RBC) count and plasma
ChE were depressed by 20% relative to con-
trols (11). The dosages eliciting reduced ChE
depression are about 3-fold lower than the no-
observed-adverse-effect levels (NOAELs)
found from animal studies, although such dif-
ferences could be due to experimental varia-
tion. Mild OP poisoning is indicated at ChE
depression of 20–50%, and in agricultural
applications workers are often removed from
exposures when ChE depression reaches 50%
of normal baseline (12,13). Although many
issues related to the use of ChE as a criterion,
including lack of baseline measurements and
laboratory variation, an emergency (48-hr)
relocation criterion of 20% RBC ChE depres-
sion was applied. A 20% RBC depression was
deﬁned as 20% below lower end normal values
or values of a particular laboratory.
Residues of MP were detected in homes
up to 3 years after spraying, requiring risk
assessments and resulting criteria develop-
ment to consider potential subchronic and
chronic effects. A 13-week, subchronic study
in dogs reported a lowest-observed-adverse-
effect level (LOAEL) at 3.0 mg MP/kg/day
and an NOAEL of 0.3 mg MP/kg/day for
systemic effects and for RBC, plasma, and
brain ChE levels (14). A 1-year dog study also
found a NOAEL of 0.3 mg/kg/day (15).
In addition to dose studies in humans,
the subchronic dog studies were selected as a
key basis on which to assess potential human
health effects. Very little difference exists in
MP toxicity between species. A 90-day rat
study submitted to the U.S. EPA to support
the registration of MP reported a NOAEL of
0.25 mg MP/kg/day, including RBC and
plasma and brain ChE levels (16). This
dosage translates to a subchronic reference
dose (RfD) of 2.5 × 10–3 mg MP/kg/day
using a uncertainty factor of 10 for extrapola-
tion from animals and humans and another
factor of 10 to account for variation in
human sensitivity (17). An RfD is an expo-
sure level derived by the U.S. EPA at which
adverse health effects are unlikely (18). A sub-
chronic RfD is often appropriate for assessing
exposures that are less than 10% of a lifetime
(7 years), such as in the case of chemical
degradation (18). In a 2-year rat study, a
dosage of 2.5 mg MP/kg/day elicited tremors
and peripheral neuropathy, and 0.25 mg
MP/kg/day elicited abnormal gait (19). The
NOAEL was 0.025 mg MP/kg/day, resulting
in a chronic RfD of 2.5E–4 mg MP/kg/day,
appropriate for assessing exposures greater
than 10% (7 years) of lifetime (20).
Subchronic information was considered more
relevant than chronic, lifetime information
because residents would not be exposed to
MP for a lifetime.
There was extensive discussion on the
establishment an MP dose considered to be
unacceptable and requiring relocation of res-
idents and decontamination of properties.
There were concerns that long-term, low-
level exposure to MP could cause chronic
neurological impairments, to both the cen-
tral and peripheral nervous systems, below
levels eliciting either symptoms of poisoning
or ChE depression. Clear evidence has been
found that chronic adverse effects occurred
after acute poisonings with OPs, although
the results were often subclinical. Case–con-
trol studies of agricultural workers reported
significant differences in memory, abstrac-
tion, or vibrotactile responses relative to
controls, ranging from 2 to 9 years after poi-
soning (21–23). Studies of long-term, low-
level exposure to OPs reported mixed
results, but some did demonstrate subclini-
cal findings. A case–control study of 45
applicators with at least an episode of ChE
inhibition but with no poisoning found no
central or peripheral nervous system effects
(24). In contrast, a study of pesticide appli-
cators with a mean exposure of 20 years
showed significant decreases in vibrotactile
sensitivity relative to controls (25). In a
case–control study of persons exposed for an
average of 15 years to pesticides in sheep
dipping, significant effects were found in
attention and information processing (26).
Animal studies of MP and other OPs also
suggested that changes in the nervous system
may occur at doses at the threshold of ChE
inhibition (0.3 mg/kg/day) (27,28).
Dose levels based on the subchronic MP
RfD (0.0025 mg/kg/day), with two uncer-
tainty and safety factors of 10 from a
NOAEL of 0.25 mg/kg/day was considered
unnecessary to protect public health because
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MP levels were declining and disappeared
within 3 years. Dose levels in the range of
0.03 mg MP/kg/day or about 10 times below
the subchronic NOAEL and 3 times below
the threshold of human Cholinesterase (CE)
depression were ultimately selected for reloca-
tion and decontamination criteria for Ohio
properties.
Exposure assessment. Field studies and
oral dosing studies provided information on
PNP excretion resulting from MP or ethyl
parathion (EP) exposures. In workers apply-
ing EP, PNP was detected in urine and was
roughly correlated with RBC and ChE
depression (29). A 10% CE depression was
associated with urinary PNP levels of 2,000
ppb, and no ChE depression was observed
below 300 ppb. PNP was considered a more
sensitive indicator of EP exposure than were
ChE measurements. In assessing worker
exposure to MP, which was dominated by the
dermal pathway, urinary PNP was also con-
sidered a more reliable exposure indicator of
exposure than was ChE depression (30,31).
With more data on the metabolism of MP,
PNP was considered to potentially provide
for a quantitative measurement of exposure.
In a later 5-day study by Morgan et al. on
four human subjects who were administered
oral MP dosages of 2 and 4 mg/day, MP
metabolites in the urine were evaluated (32).
About 90% of the PNP was excreted within 
8 hr, whereas longer times were required for
dimethylphosphate (DMP). Seventy-six per-
cent of the PNP was recovered from urine
samples compared with standards.
Quantification problems were experienced
with DMP. By doubling the mass of PNP
observed to convert to MP dose, 29% of the
MP dose was recovered within 24 hr for both
2 and 4 mg/day dosage groups.
In Lorain, Ohio, daily MP exposure could
be estimated from PNP urine data, as found in
the study by Morgan et al. (32). Although
there were recognized uncertainties in the
method, including using a method based on
an oral dose when the environmental expo-
sures are likely to be dermally driven, the
approach was considered less uncertain than
using conventional risk assessment approaches.
Initially, risk assessment techniques were used
to establish surface levels of concern.
Converting pesticide surface concentrations
into estimates of dermal exposure values is par-
ticularly difficult because exposure estimates
are based on many assumptions, including the
time spent within the contaminated area, the
frequency of contact, the age of the person,
transfer to clothing and skin, and absorption.
Yet dermal exposure in this MP case was con-
sidered to be the dominant route of exposure.
PNP urine data provided a better estimate of
total MP exposure from dermal, inhalation,
and direct ingestion pathways. The collection
of 24 total urine samples from young children
was impractical, leading to the use of twice-
daily (morning and evening) urine samples
and data on urine production rates. To pro-
vide a conservative assessment, an upper range
of urine production of 29 mL/kg of body
weight per day from 17 studies on children
was applied (33). Because this rate was similar
to the upper end found for adult males
(1.75 L/day), it was applied to all populations.
Four levels of priority were established in
Ohio based on MP environmental levels and
exposures. Concentrations of MP in the
indoor air and on surfaces and PNP levels in
the urine were independently applied to trig-
ger actions (Table 1). An estimated MP dose
greater than or equal to 0.1 mg/kg/day, the
threshold of ChE depression, was selected as
the criterion for rapid relocation (category L-1, 
within 48 hr). A dose of 0.1 mg MP/kg/day
was converted into the equivalent of 600 ppb
of PNP in the urine using the following equa-
tion, based on the work of Morgan et al. and
measured rates of daily urine production per
body weight (32,33). For children and adults
6 years of age and older, a urine concentra-
tion of 600 ppb PNP triggered relocation
within 48 hr.
An additional safety factor of 4 was provided
for infants 1 year or younger, resulting in a
PNP rapid relocation action level of 150 ppb
or a dose of approximately 0.025 mg
MP/kg/day. A safety factor of 2 was
established for pregnant women and children
between 1 and 6 years of age, yielding an
action level of 300 ppb PNP, or an MP dose
of approximately 0.050 mg MP/kg/day.
An L-2 category for priority relocation
(1 week) was established for individuals having
PNP urine levels one-third those of L-1: ≥50
< 150 ppb for infants younger than 1 year,
100–300 ppb for pregnant women and chil-
dren 1–5 years of age, and ≥200 < 600 ppb for
adults and children older than 5 years. This cat-
egorization yielded protection from estimated
MP doses of 0.008 mg/kg or greater for infants
1 year or younger, 0.016 mg/kg/day for preg-
nant women and children 1–5 years of age, and
0.033 mg/kg/day for all others. An 
L-3 category (limited or no action) designated
persons having urine levels 3 times lower than
L-2 (10 times lower than L-1). An L-4 category
(no action) designated individuals with PNP
urine levels 30 times or more below L-1 levels.
Relocation decisions were based on PNP
values unadjusted for creatinine within the
first few weeks of the project, then later on
creatinine-adjusted PNP levels. A morning
and evening urine sample was taken from each
person, and relocations were based on whether
the average of the two measurements exceeded
PNP health criteria. Although urine informa-
tion was considered ideal because it integrated
exposure routes, obtaining urine results took
several weeks until a more rapid analytical
method was developed by the CDC. In addi-
tion some persons were reluctant to provide
urine samples, and collecting urine from very
young children and infants was not always
successful. In Ohio, the use of environmental
data, which were available within a few days
after collection, was considered necessary to
protect public health.
Simple regressions were performed of
surface and air concentrations versus urine
PNP levels, unadjusted for creatinine
(Figures 1, 2). An average of MP surface lev-
els versus PNP urine levels from 22 proper-
ties and 35 people, including children,
revealed a very rough correlation (r = 0.67)
between surface and unadjusted urine levels
(Figure 1). Urine PNP concentrations were
Value of PNP in urine
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Table 1. Action levels at Lorain, Ohio.a
Category
L-1 L-2 L-3 L-4
Parameter Rapid relocation Priority Minimal/no action No action
Urine PNP (µg/L)b
<1 year of age ≥150 ≥50 < 150 ≥5 < 50 <5
1–5 years of age and
pregnant women ≥300 ≥100 < 300 ≥10 < 100 <10
>5 years of age ≥600 ≥200 < 600 ≥20 < 200 <20
Wipe (µg/100 cm2) ≥150 ≥50 < 150 ≥15 < 50 <15
Air (µg/m3) ≥10 ≥3 < 10 <3 <3
aData from Clark (8). bCreatinine adjusted. Figure 1. PNP in urine versus mean surface MP.
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concentrations. From this regression, an
average surface concentration of 120 µg
MP/100 cm2 or greater corresponded to
average unadjusted PNP urine levels of about
600 ppb for all groups. Only 1 of 12 chil-
dren 1–5 years of age from 10 households
with average MP levels below 150 µg/100 cm2
had urine levels above the 300 ppb PNP trig-
ger for emergency relocation of young chil-
dren. The child had a PNP level of 530 ppb.
Six individuals in 3 of 5 households with sur-
face MP levels greater than 150 µg/100 cm2
(an emergency relocation criterion) had PNP
urine levels above the 600 ppb PNP criterion
for emergency relocation (L-1).
Average surface levels of 40 µg MP/100 cm2
were associated with PNP concentrations of
200 ppb for all populations, a value selected
for rapid relocation (within 2 weeks) of per-
sons 6 years of age and older. Two of seven
children, 2–5 years of age, from 8 households
with MP averaging below 50 µg/100 cm2
had urine levels over the 100-ppb PNP crite-
rion used for rapid relocation (L-2) for this
age group and pregnant women. The two
children had PNP urine concentrations of
200 ppb and 110 ppb, the latter being just
marginally above the 100 ppb trigger for
rapid relocation. Seven of 12 persons from
10 households with surface concentrations of
50–150 µg/100 cm2 had PNP urine levels
less than the 200 ppb L-2 trigger. An MP
value ≥50 µg/100 cm2 and <150 µg/100 cm2
was selected to categorize properties for
decontamination and persons for priority
relocation (L-2).
Residential properties were placed in an
L-3 rating (minimal or no action) if surface
MP levels were between ≥15 µg/100 cm2 but
<50 µg/100 cm2. At MP surface levels of 15
µg/100 cm2 or lower, designated as L-4 or no
action, no individuals were found with PNP
urine concentrations above 100 ppb.
Although the relationships between surface
and urine levels were recognized as being very
crude and the number of observations small,
there was also a recognized need to protect
public health using available information.
A regression of MP air concentrations
versus PNP in urine found an r value of
0.64 (Figure 2). Urine levels of PNP were
approximately 70 times air concentrations.
An emergency relocation trigger value (L-1)
of 10 µg MP/m3 was selected, approximat-
ing PNP urine concentrations of 600 ppb.
At air levels below 10 µg MP/m3, for chil-
dren between 2 and 5 years of age, 1 in 5
had urine levels above 300 ppb, an emer-
gency relation criterion for this group. This
child had 530 ppb PNP. A rapid relocation
trigger (L-2) of 3 µg MP/m3 and greater was
selected because the air concentration
corresponded to PNP urine values of about
200 ppb. At air levels below 3 µg MP/m3,
which categorized properties as L-3, 1 child
in 4 had PNP concentrations above 
100 ppb, the rapid relocation criterion for
children 1–5 years old. At MP air concentra-
tions of 1 µg/m3 or less, no persons had
PNP urine levels greater than 100 ppb.
A regression (r = 0.69) of MP air and
surface concentrations provided additional
support for the selection of criteria
(Figure 3). Although substantial variability
existed, surface levels of 150 µg/100 cm2
were associated with MP air concentrations
of about 7 µg/m3, close to the 10 µg/m3 L-1
criterion derived from urine data, whereas
surface levels of 50 µg/100 cm2 were associ-
ated with MP air levels of about 2 µg/m3,
compared with the 3 µg/m3 L-2 criterion.
In Lorain, Ohio, each surface, air, urine,
and ChE criterion was applied independently
for L-1 and L-2 groups. That is, an exceedance
of any one criterion in the groups would trig-
ger temporary relocation of families and
cleanup. Surface data, which became available
sooner than air or urine data, were the primary
drivers for relocations in Ohio. Urine PNP was
the sole determinant in relocation and decont-
amination decisions involving L-3 properties.
Decontamination of residential properties.
The U.S. EPA Region 5 Ofﬁce of Superfund
in Chicago became involved in the cleanup
process because of unwillingness and inability
of the pesticide applicator in Ohio to deconta-
minate residences. U.S. EPA actions, which
included relocation of residents, decontamina-
tion, and restoration of properties, were con-
ducted. After meeting with local, state, and
federal agencies, a command and control
system was established by U.S. EPA on-scene
coordinators.
On finding that either environmental
levels of MP or urine levels of PNP exceeded
health criteria, a written notiﬁcation was pro-
vided by local health departments to owners
and residents that described potential health
risks and the need to evacuate the properties.
Immediately on issuance of the communica-
tion, teams consisting of public affairs spe-
cialists and local health personnel met
directly with residents and property owners.
Affected persons received information on
health risks of MP, relocation, MP deconta-
mination of clothing and linens, and packing
instructions (34). To remove MP residues,
residents were instructed to wash clothing 2
or 3 times with liquid detergent and hot
water (35,36). Residents were also provided
information recommending that all items
(excluding clothes and linens) used for babies
and small children; drapes/window treat-
ments, rugs, and carpets; children’s toys;
food products; kitchen wood and plastic
utensils; personal products; and any contami-
nated furniture should to be left in the home
to be disposed of by the decontamination
crews. The cost of all contaminated furniture
(including mattresses); infant furniture
(including strollers, car seats, cribs, crib mat-
tresses, walkers, and playpens); and children’s
toys would be considered for reimbursement
by the U.S. EPA. Other items would not be
considered for reimbursement.
The U.S. EPA obtained access agreements
from the residents and the owners of each res-
idence before decontamination. U.S. EPA
determined that decontamination would
impact residents requiring their temporary
relocation (1). A direct communication link
between the cleanup operations and the resi-
dents was developed. This was especially
important for working with the local
Hispanic/Latino community, many of whom
required translations of materials.
Before decontamination, documentation
of each residence was conducted with video-
tape and photographs of the interior and exte-
rior of the residence, noting the condition of
the dwelling and all sensitive possessions that
remained on site. If friable asbestos was sus-
pected or observed, a certiﬁed asbestos inspec-
tor collected samples and an asbestos
contractor conducted asbestos removal before
MP decontamination. Household belongings
were removed to storage containers. High-con-
tact items, such as toys, were disposed of on
the basis of the decontamination procedures
and the terms of the access agreement.
As was the case in creating the MP action
levels, the decontamination protocol under-
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Figure 2. PNP in urine versus MP in air.
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Figure 3. MP air levels versus MP mean surface
levels.
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r = 0.69went signiﬁcant evolution. Decontamination
criteria were developed that required that the
residence meet an average of 50 µg
MP/100 cm2, with no values higher than
50 µg MP/100 cm2 in bedrooms, living
rooms, and bathrooms. A goal of 5 µg
MP/100 cm2 was established but not required
for living rooms and bedrooms. Areas of low
contact, such as utility rooms and under the
sink, were permitted to have up to 150 µg
MP/100 cm2. All air samples were required to
have less than 3 µg MP/m3. Four homes with
the highest surface levels of MP were selected
for decontamination tests. Initial attempts
were made to decontaminate surfaces with an
ammonia fog (NH4OH in humidifiers) at
temperatures of 80°F. This technique was suc-
cessful on hard surfaces such as metal in duct-
work, but it was unsuccessful on porous
surfaces such as wood and wallboards or for
fabrics and carpeting (1). Attempts were then
made to clean surfaces with a mixture of
ammonium hydroxide, water, and isopropyl
alcohol. After decontamination and postde-
contamination sampling, residences often did
not meet the decontamination target criteria
and required recleaning 2 and often 3 times.
Because of the ineffectiveness of the initial
decontamination solution, the decontamina-
tion protocol was modiﬁed.
The new decontamination protocol
included the removal of all carpets, window
treatments, furnace filters, furniture, mat-
tresses, and food products from the residence
(1). A commercially available solution,
UltraKleen (UK; Sterilux Corp., Owings
Mill, MD, USA), was used as the primary
decontamination solution. The product is a
caustic solution with a pH of about 12 and
was found to rapidly hydrolyze MP to PNP.
UK was developed as a food-contact hard sur-
face cleaner decontaminant, primarily used
for cleaning equipment at meat and poultry
plants. All decontamination work was com-
pleted in Level C personal protective equip-
ment (air purifying respirator and
chemical-resistant suit). The decontamination
protocol was a stepped process. First, the
entire unit was sprayed with a dilute 2% UK
solution (Figure 4). The resulting yellow
color from PNP was used by the field crews
to identify spray patterns of the exterminator,
help concentrate their cleanup efforts, and
thus aid in the decontamination process. The
second step was to thoroughly scrub a 15%
UK solution into and over all surfaces. This
was followed by a sponge wipe of all surfaces
with a 2% UK solution, which in heavily
stained areas was followed by another 15%
UK wash. These steps were repeated as often
as necessary until all visible yellow PNP
coloration was gone.
After completion of the UK wash, all
surfaces were wiped with a vinegar and water
solution to remove any residual PNP (1). The
final step was to wipe all surfaces with clean
water to remove all UK and vinegar residues.
In addition, all appliances, cookware, dishes,
and drinking glasses were washed with a 5%
UK solution and thoroughly rinsed with 
fresh water to remove any residues. After the
decontamination procedure, a high-efﬁciency
particulate air (HEPA) ﬁlter vacuum unit was
used to remove all particulates from the resi-
dence and to complete the decontamination.
Furnaces were set at 80°F and a 12-hr ammo-
nia fog (NH4OH) in humidiﬁers was used to
reach areas such as ductwork that were difﬁcult
to reach.
However, shortly after beginning to use
this new protocol, decontamination teams
observed the recontamination of some surfaces
that previously had been cleaned. Some heav-
ily contaminated surfaces (e.g., wood base-
boards, drywall, plaster, wood cabinets) had
absorbed the pesticide and became recontami-
nated as the UK solution wicked the pesticide
to the surface.
After a detailed cost evaluation of repeated
decontamination with solutions versus replace-
ment of contaminated materials, the deconta-
mination protocol was later amended to
include the removal of baseboards, lower por-
tions of the dry wall, kitchen cabinets, ceilings,
and any other portion of the house structure
that remained contaminated after an initial
decontamination attempt (Figure 5). After
these procedural changes, the time required to
complete the decontamination of the residence
was reduced, as were costs.
Sampling was also conducted 10–12 hr
after the decontamination teams completed
their work, and indoor temperatures were
returned to 72°F (1). The sampling protocol
after decontamination consisted of both wipe
and air samples collected to verify the effective-
ness of the residential cleanup and to allow the
initiation of the restoration phase. A minimum
of two and a maximum of four air samples
were collected from each residence, at least one
sample from each floor of the residence.
Between 8 and 12 wipe samples were collected
from each home, depending on the number of
rooms in the residence. Air and wipe samples
were analyzed by Roy F. Weston, Inc.,
Laboratories (Edison, NY, USA) using
NIOSH method 5600 for wipe samples and
modiﬁed 5600 method for air samples.
The analytical results usually were received
within 48 hr, and the data were reviewed
against the preestablished target cleanup crite-
ria. If the home met cleanup criteria, the resi-
dence would be immediately referred to the
restoration phase. If the analytical data did not
meet target cleanup levels, the unit was
returned to the decontamination phase for
“spot” decontamination of the “hot” areas, as
identified in the sampling results. The spot
decontamination was continued until target
cleanup levels were achieved and the residence
could be referred to the restoration program.
In early February 1995 U.S. EPA
contractors began restoring the decontaminated
homes in Ohio (1). Restoration of each unit
was designed to return each unit to preexisting
condition and to repair damage caused by the
destructive decontamination procedures.
Restoration included sealing walls and ceilings
and portions of the ﬂoors with an alcohol-based
primer, hanging new and repairing existing
drywall, painting ceilings and walls, installing
baseboards and cabinets in the kitchen, hook-
ing up all appliances and plumbing, and
installing carpeting and padding. The alcohol-
based primer sealant was used to create a 2- to
3-mm thick barrier that was found to prevent
MP from leaching through to the drywall sur-
face. Before the return of the residents, a video
documentation of each residence was made.
Stored belongings and furniture not found to
be contaminated were moved back into the res-
idence and photographed, and their condition
was documented and decontaminated or
disposed.
Results
Environmental and urine data. A total of
480 properties in Ohio were investigated
and sampled for MP contamination by the
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Figure 4. Decontamination of surfaces. Figure 5. Residences with drywall removed.State of Ohio. Ultimately, the Ohio
Department of Agriculture analyzed more
than 7,000 samples for MP and other OPs
within a 6-month period. Another 250
properties were independently investigated
by the U.S. Department of Housing and
Urban Development. None of these proper-
ties were found to have MP levels above the
criteria. The distributions of individuals by
categories of PNP, mean MP surface levels
(L-1, L-2, L-3, L-4), and age categories are
presented in Figure 6. Most individuals had
PNP concentrations below levels of poten-
tial concern, especially in L-4 and L-3 cate-
gories. However, the data show that as MP
surface concentrations increase, the number
of individuals above PNP exposure criteria
increases.
Once the CDC established a rapid method
for urine analysis, this measure became the
dominant criterion for evaluating persons in 
L-3 properties. Several small studies were con-
ducted on L-2 and L-3 properties and persons
to assess short-term variation in urine levels
(Table 2), changes in exposure over time, MP
concentrations on high-contact surfaces, and
PNP in the environment (Table 3). Variation
in exposure to MP was believed to be highly
dependent on amount of time spent inside the
property, age of the individual, amount of con-
tact with hot spots, degree of clothing contam-
ination, and individual behavior. To assess
variation in PNP, repeated urine testing was
conducted on a subset of persons in 20 L-3
properties over 2 days. In eight children from
whom four urine samples were collected
(2 A.M. and 2 P.M.), the range in highest to
lowest urine levels averaged about 2-fold
(Table 2). Samples collected in the morning
tended to have higher PNP concentrations and
less variability than those collected in the
afternoon. In 3 (15%) of the 20 properties,
average urine levels were above the MP expo-
sure protocol when MP concentrations were
less than the 50 µg/100 cm2 L-3 criterion. The
highest single PNP urine level found in a child
in L-3 properties was 254 ppb compared with
the 100 ppb L-3 criterion. To assess exposure
over time and to ensure that more highly
exposed individuals were not missed, persons
in L-3 properties were retested about 4 months
after initial testing. Overall, retesting found
that average PNP urine levels had declined
from 87 to 42 ppb, or a reduction of about
50% in 4 months. Ten children of 101 per-
sons tested after 4 months still had urine levels
> 100 ppb PNP, resulting in decontamination
of a few L-3 properties.
The protocol applied baseboard surface
samples from lower-contact areas as an rough
index of potential exposure. A study of eight L-3 
properties was conducted to assess potential
exposure from higher-contact surfaces such as
floors and carpets. Wipe samples were taken
from both floors and carpets (wet and dry
wipes) in living rooms, bedrooms, kitchen, and
hallways. Although these higher-contact areas
averaged 1.2 µg MP/100 cm2, 32 times less
than the average samples taken from base-
boards, they likely represented a dermal expo-
sure route as reported in other OP studies
(37,38). Clothing likely represented another
major exposure route (35). Most carpet wipe
samples had nondetectable levels of MP (<1
µg/100 cm2). Two carpets from L-2 properties
were evaluated for potential bioavailability data
via wipe samples versus the total amount of MP
in the carpet. Wet wipes of carpeting from the
center of the rooms and near walls revealed MP
concentrations ranging from nondetectable to a
maximum of 4 µg/100 cm2, with a mean of
0.75 µg/100 cm2. Total amount of MP in the
total carpet samples were considerably higher,
ranging from nondetectable to 169 µg/100
cm2, with a mean of 76 µg/100 cm2. The high-
est levels were found near walls. The data
clearly indicated that carpets were signiﬁcant
MP sinks. The removal of all carpeting and
decontamination of surfaces in L-1 and L-2
homes ensured that future MP exposures
would be minimized. Because the pesticide lev-
els were very low and near the detection limit
on these higher-contact surfaces, an improved
exposure protocol was not developed.
The amount of exposure via ingestion of
dust was evaluated in four L-3 homes that
had MP baseboard concentrations averaging
30 µg/100 cm2. Dust from the houses col-
lected from vacuum cleaners averaged 3.5 mg
MP/kg. Assuming 1,000 mg of soil/dust
intake (90th percentile) per day, the MP dose
would have been about 3.5 µg of MP/day
(39). Urine concentrations of PNP in chil-
dren averaged 86 ppb, unadjusted for creati-
nine, yielding a estimated dose of 0.27 mg
MP/day using urine production rates per
body weight and the equation from Morgan
et al. (32). Based on this analysis, oral expo-
sure to MP in dust constituted about 1% of
that observed from urine. Although relatively
high detection limits were applied, these ﬁnd-
ings are consistent with the NIOSH study
conducted in December 1994 on 30 children
18 months or younger (40). An entire hand
(front, back, between fingers) was washed
with alcohol on gauze. At a limit of detection
of 8–30 µg, 29 wipe samples were negative
and one was positive at 10 µg.
Environmental PNP. MP is known to
break down in soils, with PNP being a
potential transitory intermediate product
(41). Other information has been reported
that MP may be biodegraded directly to car-
bon dioxide or a volatile compound (42).
Human exposure to environmental PNP
results in urinary excretion of PNP that
would be indistinguishable from metaboli-
cally derived PNP resulting from MP expo-
sure. Six L-3 houses in Ohio were evaluated
to assess MP and PNP environmental levels.
If the environmental PNP average concentra-
tions were found to be low relative to MP or
found only in isolated areas of the
households, then there would be no change
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Figure 6. Number of individuals by PNP, MP mean surface level, and age group.
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Table 2. Variation in PNP urine levels.a
Age (years) PNP range (ppb) Range (multiplier)
66 3–120 1.9
92 6–34 1.3
83 8–95 2.5
73 8–68 1.8
11 40–130 3.2
61 30–254 1.9
51 20–240 2.0
88 1–120 1.5
aBased on four samples per child, creatinine adjusted,
from L-3 residences (≤50 µg/100 cm2).in the protocol. If the environmental PNP
were found to be significant or if it were
found throughout the residence, then an
approach would be developed to correct the
urinary PNP values based on the ratio of
environmental PNP to MP and comparative
toxicities of PNP and MP.
L-3 Ohio homes were tested for MP and
PNP by obtaining seven side-by-side base-
board samples from each home. Dust sam-
ples were also collected from vacuum
cleaners and analyzed for MP and PNP. All
samples from all homes had detectable levels
of MP (Table 3). Two homes had no
detectable environmental PNP, whereas two
had detectable levels in only a single location
(under the sink, bathroom). The locations
where PNP was found are those where water
or ammonia-based cleaning agents are most
likely to be applied. Both water and particu-
larly bases hydrolyze the DMP group of MP,
resulting in the PNP derivative. One house
had a detectable level of PNP only in the liv-
ing room. One house had detectable PNP
levels by the sink, under the sink, and in a
bathroom. Dust samples had no detectable
levels of PNP but did have MP. Although
the average of environmental PNP greatly
exceeded MP in one house and was about
equal in another, the areas affected with
PNP were small compared with the total
property area. Also, no PNP was found in
bedrooms of any home, where exposures
were likely to occur. Because PNP environ-
mental levels were generally low and in small
areas in Ohio properties, no changes in the
protocol were made.
Decontamination results. In Ohio, 233
properties were decontaminated. It took about
6 weeks for the entire process of relocation,
decontamination, restoration, and reoccu-
pancy to take place. Properties being deconta-
minated without removal of baseboards and
drywall had resultant MP surface concentra-
tions averaging 21 µg/100 cm2 and air levels of
0.9 µg/m3. These surface concentrations were
about 5-fold lower than concentrations before
decontamination, whereas air levels were about
8-fold lower than initial MP concentrations.
Postdecontamination results in homes where
contaminated baseboards and drywall were
removed had average surface levels of
3µ gMP/100 cm2 and average air levels of
0.7 µg/m3. These MP surface and air concen-
trations were, respectively, approximately 35
and 10 times less than initial surface and air
concentrations. To ensure that the decontami-
nation process was completely effective, eight
properties that had among the highest MP
concentrations found before decontamination
were selected for short-term and longer-term
monitoring. Wipe and air samples showed no
significant differences in MP concentrations
over time, which is likely related to concentra-
tions being near the detection limit. MP sur-
face concentrations averaged 1.2, 2.0, and 2.0
µg/100 cm2 and MP air levels averaged 0.7,
0.7, and 0.6 µg/m3, respectively, at 7, 30, and
90 days after restoration. Urine tests from 34
persons from 12 L-1 decontaminated resi-
dences revealed very low PNP exposures.
Twenty individuals, mostly young children,
had nondetectable (<25 ppb) PNP urine levels.
Ten individuals had detectable urine levels
averaging 44 ppb PNP (creatinine adjusted),
with a maximum value of 110 ppb, slightly
over the 100 ppb L-3 criterion for children
1–5 years of age. Laboratory data were unavail-
able on four individuals. The single high urine
value was linked to a child’s mattress that had
not been removed during decontamination.
Evaluation of the protocol used at Lorain,
Ohio. After completion of the Ohio MP
investigation and decontamination of 233
residences, the entire MP and urine PNP
database was examined to assess the outcomes
resulting from the decision-making protocol.
Of particular interest was how well the
process, using rough correlations on initially
collected data, successfully categorized expo-
sure groups. For example, a correct positive
decision would have been one where mean
surface MP concentrations were ≥ 50 µg
MP/100 cm2 and PNP levels were ≥ 50 ppb
in infants younger than 1 year. All individuals
in residences having concentrations greater
than these criteria would be subject to reloca-
tion and their properties would be decontam-
inated. A false negative was characterized as
residences with surface levels < 50 µg
MP/100 cm2 but with urine PNP > 50 ppb
in infants. Results by age group and MP sur-
face concentrations are presented in Figure 7.
Categorizations were correct for 72% of
infants and 64% of children 1–5 years of age
and pregnant women, whereas false negatives
were 9 and 7% and false positives were 9 and
28%, respectively, for these two groups. With
the >5 year age group, correct categorization
fell to 30% and false positives increased to
65%; false negatives were less than 1%.
On a household basis the correct
categorization was made 54% of the time,
with 46% false positives (Figure 8).
Therefore, almost half the properties did
not have individuals with PNP exposures
that exceeded their PNP criteria based on
average PNP levels from two urine samples.
About 1% of the properties had average MP
surface levels below 50 µg MP/100 cm2 L-3
criterion (no-action) but had individuals
with PNP urine levels above L-2 (deconta-
mination) criteria. A portion of the false
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Table 3. MP and PNP in homes.
Home MP positivea Mean MPb PNP positivea,c Mean PNPb
1 6/6 63.7 0/6 <1
2 6/6 49.9 0/6 <1
3 6/6 42.9 1/6 (s) 16
4 6/6 18.8 1/6 (us) 18
5 6/6 11.7 1/6 (l) 3.8
6 6/6 35.4 3/6 (s, us, l) 77.9
aNumber of samples positive out of total. bValues in µg/100 cm2. cs = sink, us = under sink, l = living room.
Figure 7. Decision outcome by MP surface level, PNP, and age group.
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Figure 8. Decision outcome by household (by MP
surface level, PNP, and age group).
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Householdspositive results in households may have
been due to variation in spot urine samples.
A study of L-3 children had found that spot
urine PNP levels could vary by about 2-fold
(Table 2).
Regressions of all available PNP data
versus mean surface MP levels demonstrated
variation in the data and were different from
those performed before most data were col-
lected (Figure 9). However, the regressions
of PNP to MP were statistically significant
(p < 0.0001) for the 1- to 5-year and >5-year
age groups and also provided support for
selecting 50 µg/100 cm2 as a relocation cri-
terion in Ohio. For the 1- to 5-year age
group, the resultant linear regression equa-
tion was PNP = 0.34 (MP) + 101.8, with a
correlation of r = 0.52. The intercept was
also significant (p < 0.0001). Forcing the
line through the intercept improved the lin-
ear relationship (r = 0.66) and could be jus-
tiﬁed by the extremely low levels of PNP in
persons not exposed to MP. However, the
linear equation with the statistically signifi-
cant intercept also had better residual
analysis results and had a lower root mean
square error.
Correlations were weaker (r = 0.16) for
infants and for individuals older than 5 years
(r = 0.38, p < 0.0001). Weaker correlations
would be expected for persons 5 years of age
and older because of increased time spent
outside households. As in the case of the 1- to
5-year age group, the intercept for the
>5-year age group was statistically signiﬁcant 
(p < 0.0001). Because the positive intercepts
(1- to 5-year and >5-year age groups) were
unlikely due to chance, it suggests that there
were other sources of MP exposure. Surface
samples from baseboards and under the sink
were only indicators of potential exposure.
Higher-contact surfaces such as carpets,
clothing, linens, and furniture were also
found to be contaminated with MP, probably
due to MP volatilization, and they would be
expected to be a dominant exposure route.
Inhalation and oral (e.g., dishes or food) MP
exposures also would have occurred.
Development of a national methyl
parathion protocol. After MP was found in
residential and commercial properties in
Pascagoula, Mississippi, and soon after in
Louisiana, Alabama, and Tennessee, concerns
were raised about whether the Lorain, Ohio,
protocol, which was based on an initial evalu-
ation of the relationship between environmen-
tal MP and urine PNP in northern properties
treated by one sprayer, would be fully appro-
priate in a situation involving southern prop-
erties where multiple applicators were
involved. In the South, homes generally were
not as extensively sprayed as they were in
Ohio. In addition, only weak correlations
were found in Ohio.
A Methyl Parathion Health Sciences
Steering Committee, consisting of state and
federal health ofﬁcials, was established by the
U.S. EPA Office of Emergency and
Remedial Response to evaluate these more
recent incidents and determine if the Lorain,
Ohio, protocol should be modified.
Scientists who had developed the Lorain,
Ohio protocol also participated.
Toxicological literature and the usefulness of
using urine PNP as an exclusive basis for
relocation or in conjunction with environ-
mental MP was extensively re-reviewed. In
contrast to the early findings in Ohio,
ATSDR found virtually no correlations with
environmental MP and urine MP in
Louisiana (43). Therefore, in the absence of
reasonable correlations, the committee rec-
ommended that urine PNP and not environ-
mental MP should drive future relocation
decision making. The committee also con-
cluded that urine-based PNP relocation cri-
teria for adults and older children could be
raised without signiﬁcantly increasing health
risks. These PNP relocation levels more
closely matched L-1 emergency relocation
values used in Ohio but were lowered to 50
ppb PNP to provide greater protection of the
fetuses for pregnant women exposed to MP.
Infants younger than 1 year were also pro-
tected at 50 ppb PNP. The enhanced level of
protection for fetuses and young infants was
based on information indicating that their
MP metabolism would be more restricted
(44–46). The ATSDR developed an
improved questionnaire that obtained more
information on the amount of time each
individual spent in the home and their activi-
ties 24 hr before urine collection. More
emphasis was placed on environmental
sample collection from areas of higher
contact. For instance, under the kitchen sink
samples were eliminated. As in the Lorain,
Ohio protocol, the committee concluded
that cleanup levels derived from chronic
RfDs were not needed because MP levels
declined to nondetectable levels within a few
years. After an external peer review process
overseen by the ATSDR (44,45), a national
MP protocol was finalized (47) (Table 4).
Overall, nearly 7,000 properties were sam-
pled during the 1994–1997 MP investiga-
tion and about 1,000 residences were
decontaminated (Table 5) (2). The pesticide
misuse investigation and decontamination
effort was the largest project of its type ever
conducted by federal and state agencies.
Discussion
The risk assessment–risk management
approach used in Ohio, although based on
crude regressions using limited data collected
early in the assessment process, yielded an
appropriate degree of protection for infants
younger than 1 year. Assuming one infant per
household, about 90% (correct plus false posi-
tives) of the residences having infants younger
than 1 year would be considered safe for occu-
pancy using only the surface MP criterion.
Infants born into homes or new families with
infants moving into properties having less than
50 µg MP/100 cm2 would be protected. Such
approaches and outcomes are consistent with
risk assessment and risk management
approaches under Superfund procedures,
which apply risk characterizations and decont-
amination criteria to protect the most vulnera-
ble populations, often at 95th exposure
percentiles (18). For instance, in the case of
lead in residential soils, decontaminated targets
Methyl Parathion • Clark et al.
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Figure 9. Regression of PNP in urine versus mean surface MP.
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r = 0.66are established such that there is only a 5%
chance that a young child will exceed the lead
blood level health criterion of 10 µg/dL (48).
Modiﬁcations in the Ohio protocol were
necessary when MP exposures in Mississippi
were found to be considerably lower than
those in Ohio. Differences in housing, cli-
mate, and spraying practices were believed
responsible for these differences. By placing
emphasis exclusively on actual exposures as
measured by urine PNP, there were fewer
relocations. The quarterly monitoring of resi-
dents who were not relocated provided a pro-
tective approach, although there were
limitations. For example, because MP residues
could last several years and urine monitoring
was required for only a year, PNP levels could
be above the 50 ppb criterion for women who
became pregnant or infants born into house-
holds after a year. However, it is highly
unlikely that persons were at significant risk
because exposure to environmental PNP may
have been occurring.
In Chicago, Illinois, testing of 13
properties found mean surface levels of PNP
almost 3 times the MP levels (49). In contrast
to the Illinois ﬁndings, tests on Ohio proper-
ties found PNP levels averaging 70% of MP
levels. For Chicago properties, there appeared
to be no clear relationship between the ratio
of PNP to MP and the length of time (11–66
months) after spraying or the concentration
of MP. Unlike the ﬁndings in Lorain, Ohio,
every living area in every Chicago home
tested was positive for PNP.
The Chicago results, which came late in
the national assessment process, strongly sug-
gest that urine PNP levels were based on
exposures to both MP and environmental
PNP. Although this raises doubts about urine
PNP as an exposure criterion, the approach
may have been appropriate. First, urine PNP
did provide a measure of total exposure to
two toxic chemicals, MP and PNP. PNP
causes increases in methemoglobin and death
in rats at doses of 70 mg/kg body weight per
day (50). PNP also is a respiratory, eye, and
skin irritant. Although the oral NOAEL 
(25 mg/kg body weight per day) for PNP is
100 times higher than that reported from MP
subchronic studies, it has a relatively low RfD
(0.008 mg PNP/kg body weight per day)
because of uncertainties in its toxicology (50).
Second, there is evidence that dermal
exposure to environmental PNP could
enhance MP absorption, as is the case for EP
(43). Finally, although definitive dermal
studies need to be conducted, as recom-
mended by the ATSDR expert panel, in the
absence of such data it would not be an inap-
propriate risk management approach to
assume that all urine PNP has been derived
from MP exposure. However, the Chicago
findings of extensive environmental PNP in
properties demonstrate the need to better
understand environmental PNP formation
and to develop an assessment approach that
is based on either a) ratios of environmental
PNP and MP levels and toxicities or b)
methods that could differentiate between
exposures resulting from environmental MP
and PNP. Urine testing of methyl phos-
phates, a derivative of MP metabolism, could
provide an approach to distinguish between
metabolic PNP and environmental PNP.
More sophisticated exposure approaches are
also needed that better determine or model
dermal exposures to MP and other OPs (51).
The MP exposure studies in Chicago applied
a more refined approach using composite
surface samples from high-contact areas such
as ﬂoors (48).
In response to the extensive illegal use of
MP, the U.S. EPA required modiﬁcations in
the registration of MP products and initiated a
residential pesticide control program (52,53).
Specifically, the U.S. EPA required
Cheminova, the sole manufacturer of MP, to
a) use no more than 5 pounds of MP per gal-
lon; b) have returnable, refillable containers
that have tamper-resistant openings and are
designed for use only with agricultural spray
equipment; c) include a bar coding system to
track the sale and disposal of containers; and d)
add a stenching agent in the formulation that
would alert persons if the product were used
inside properties (52). In 1999, because of MP
residues in some foods and potential risks, the
U.S. EPA canceled MP use on crops such as
apples, grapes, carrots, lettuce, and tomatoes
(53). Uses on nonfood crops such as ornamen-
tals and nursery stock were also eliminated. To
help prevent future misuse, training of pesti-
cide applicators and alerts to state inspectors
and retailers of MP products were initiated
(52). Those responsible for the MP spraying in
Ohio, Illinois, and Mississippi were convicted
of felonies, and some users served time in jail.
However, solving the problem of illegal pesti-
cide use will clearly require constant vigilance
and aggressive enforcement.
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